Regional cerebral oxygen saturation
12 papers study it2 more mention it6 findings
1 new paper in 30 daysSee all 14
- Human trial6
- Humans3
Interventions
2Permissive hypercapnia
upin humans2
2 studies
Permissive hypercapnia
upin humans2
Permissive hypercapnia increases regional cerebral oxygen saturation in humans (left: aMD 10.64, 95% CI 8.96-12.33; right: aMD 10.16, 95% CI 8.22-12.11; both P < 0.001).
“PHC significantly increased rSO2 relative to conventional ventilation (left: adjusted mean difference [aMD] 10.64, 95% CI 8.96-12.33; right: aMD 10.16, 95% CI 8.22-12.11; both P < 0.001)”
Human trialnon-acute fragile brain function undergoing elective laparoscopic colorectal surgeryn = 76
Experimental gerontology
Permissive hypercapnia improves regional cerebral oxygen saturation in humans ((64.04 ± 4.11)% vs. (56.43 ± 6.54)%).
“The intraoperative rSO2 of the PH group was considerably higher, especially 10 min after the establishment of pneumoperitoneum (t = 12.328, P < 0.05) and late during the operation [(64.04 ± 4.11)% vs. (56.43 ± 6.54)%, t = 14.778, P < 0.05].”
Humanscerebral tissue30 daysn = 450
Frontiers in medicine
Permissive hypercapnia improves regional cerebral oxygen saturation in humans (mean difference 4.62%, 95% CI 3.81-5.43; P < 0.001).
“Permissive hypercapnia was associated with significantly improved intraoperative cerebral oxygenation (rSO2) compared to conventional ventilation (mean difference 4.62%, 95% CI 3.81-5.43; P < 0.001)”
Humanslaparoscopic surgeryn = 450
Frontiers in medicine
Dexmedetomidine
upin humans1no changein humans1
2 studies
Dexmedetomidine
upin humans1no changein humans1
Dexmedetomidine increases regional cerebral oxygen saturation in humans (P < 0.05).
“Group A exhibited higher rSO2 values at the time of endotracheal intubation, 30 min after the start of surgery, and immediately after extubation”
Human trialundergoing radical colon cancer surgery
World journal of gastrointestinal surgery
Dexmedetomidine has no effect on regional cerebral oxygen saturation in humans (63.5 ± 2.52% vs. 64.2 ± 3.22%).
“The baseline rSO2 was not significantly different between the dexmedetomidine and placebo groups (dexmedetomidine 64.9 ± 2.73% vs. placebo 64.3 ± 3.29%), and no significant difference was found after the patients regained consciousness (dexmedetomidine 63.5 ± 2.52% vs. placebo 64.2 ± 3.22%).”
Human trial20 minutesn = 61
The Journal of international medical research
Dexmedetomidine has no effect on regional cerebral oxygen saturation in humans.
“The rSO2 was not significantly different between the dexmedetomidine and placebo groups.”
Human trialundergoing lobectomy by video-assisted thoracoscopic surgery20 minutes before anesthesia inductionn = 60
The Journal of international medical research